Literature DB >> 1540615

Respiratory syncytial virus pneumonia in a lung transplant recipient: case report.

J R Doud1, T Hinkamp, E R Garrity.   

Abstract

A 29-year-old man underwent bilateral lung transplantation and received maintenance immunosuppressive therapy. He was readmitted 11 months later with symptoms of cough, sneezing, and rhinorrhea. The physical examination was normal. Laboratory results were significant for a reduction of FEV1 and an interstitial infiltrate on chest films. The patient had recently undergone bronchoscopy for rejection surveillance, and 2 days before admission the bronchoalveolar lavage cultures returned positive for respiratory syncytial virus. The patient was treated with aerosolized ribavirin with complete resolution of symptoms. Respiratory syncytial virus must now be included in the list of pathogens causing pneumonia in the lung transplant recipient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540615

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

Review 1.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

2.  Respiratory syncytial virus infections in pediatric renal transplant recipients.

Authors:  R B Miller; B M Chavers
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study.

Authors:  Stuart C Sweet; Hyunsook Chin; Carol Conrad; Don Hayes; Peter S Heeger; Albert Faro; Samuel Goldfarb; Ernestina Melicoff-Portillo; Thalachallour Mohanakumar; Jonah Odim; Marc Schecter; Gregory A Storch; Gary Visner; Nikki M Williams; Karen Kesler; Lara Danziger-Isakov
Journal:  Am J Transplant       Date:  2019-07-25       Impact factor: 8.086

4.  Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.

Authors:  Ilker Uçkay; Paola M Gasche-Soccal; Laurent Kaiser; Richard Stern; Jesica Mazza-Stalder; John-David Aubert; Christian van Delden
Journal:  J Heart Lung Transplant       Date:  2009-10-17       Impact factor: 10.247

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.